FDA Inspection 993030 — Hetero Labs Limited - Unit III

Hetero Labs Limited - Unit III — FEI 3005406526

The FDA completed an inspection of Hetero Labs Limited - Unit III on October 26, 2016 in Hyderabad. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 26, 2016
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Hyderabad (India)